Global Facial Injections Market - 2022-2029

Market Overview

The Global "Facial Injections Market" is expected to grow at a high CAGR of 10.30% during the forecast period (2022 -2029).

Facial Injections inject facial fillers such as collagen, hyaluronic acid, and calcium hydroxyapatite that rejuvenate facial skin by reducing or eliminating wrinkles, raising scar depressions, enhancing lips, and replacing soft tissue. Facial injections are minimally invasive and do not involve any surgery which is typically completed during an office visit. These injections contain ingredients that add fullness to areas that have thinned due to aging. This thinning is common in the cheeks, lips, and around the mouth.

Market Dynamics

The global facial injections market growth is driven by the increasing expenditure levels on beauty products, early aging due to environmental pollution and inappropriate food habits are driving the global facial injections market over the forecast period.

The rise in demand for aesthetic procedures to drive market growth will drive the market growth

There has been the creation of various factors and also awareness, which has led to increasing demand for aesthetic procedures. Furthermore, as economic development takes place in developing countries across the world, there has been a strong increase in disposable income. This has led an increasing number of individuals to adopt various filler injections in order to induce an improvement in their aesthetic beauty. Also, there has been a significant alteration in attitudes toward these cosmetic procedures, which has reduced the stigma attached to these products.

In the current scenario, there has been an increase in demand for aesthetic procedures across all age groups, including the younger and geriatric populations. Also, the increase in the safety features of these products has further contributed to their greater adoption. For instance, according to the statistics released by the International Society of Aesthetic Plastic Surgery (ISAPS), in India in 2019, the total number of nonsurgical injectables amounted to 113,616 procedures. Furthermore, strong growth in the number of injectable facial procedures was also recorded in countries such as the United States, France, Italy, and Germany. Such strong growth trends in the procedural volume are expected to intensify the market growth.

The relative side effects and lack of permanence of facial injectables will hamper the growth of the market

However, with a strong and sustained surge in demand for aesthetic procedures such as administration of fillers and botulinum toxin, certain factors are restricting the market growth. For instance, certain side effects of these procedures include pain, swelling at the injection site, occurrence of infections, redness, bruises, and creation of bumps and lumps. Furthermore, in some rarer instances, serious side effects such as vision loss, blurred vision, scarring, and blindness have occurred if the facial injectable is administered into a blood vessel. These factors will hamper the growth of the market in the forecast period.

COVID-19 Impact Analysis

The outbreak of COVID-19 resulted in decreased public mobility and has also impacted the therapeutic and surgical industry significantly, as the surgical procedures and screening programs, which are non-immediate and are being postponed to decrease the burden on healthcare infrastructure. For instance, according to the study published in the British Journal of Surgery, in May 2020, based on a 12-week period of peak disruption to hospital services due to COVID-19, around 28.4 million elective surgeries worldwide will be canceled or postponed 2020. In addition, rising cases of COVID-19 in the countries are expected to have a short-term impact on surgical rates of cosmetic procedures. The short-term effects on the surgical segment are less prominent. However, the adverse impacts of COVID-19 on the global economy can have significant indirect effects on the surgical segment of the market.

Segment Analysis

The hyaluronic acid segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Hyaluronic acid segment growth includes known for its ability to store moisture in the skin, thus making the skin look healthier, a moisture-binding characteristic that helps enhance and maintain the vital moisture responsible for the plumpness of the facial skin. The increasing demand for aesthetic procedures and an increasing number of facial procedures are boosting segment growth.

A research article by Matt Spick et al., published in September 2020, found that most people infected with SARS-COV-2 coronavirus are likely to develop dyslipidemia and changes in their sebum liposome that can lead to premature aging of the skin in the long term which is expected to boost the market growth in coming years.

Hyaluronic acid has major benefits as it increases hydration, improves elasticity, and reverses free radical damage that protects from UV damage. These factors help in driving the overall market for hyaluronic acid. It is also seen that the demand for hyaluronic acid is increasing significantly, which is expected to provide consistent growth in the coming years in the studied market.

The market players are adopting various strategies such as product launches, developments, collaborations, partnerships, acquisitions and expansions to increase market share. For instance, in June 2020, AbbVie Inc., (Allergan Plc) received approval from the United States Food and Drug Administration (FDA) for JUVEDERM VOLUMA XC for the augmentation of the chin region in adults over the age of 21.

Geographical Analysis

North America region holds the largest market share of the global facial injections market

North America held the highest market share and is anticipated to remain the same over the forecast period due to the increasing number of facial injections related to lip augmentation and facial correction. According to the American Society of Plastic Surgeons in 2017, in the United States, the use of fillers soared from 1.8 million procedures in 2010 to 2.6 million in 2016 showcasing the rapid growth of the facial injections market. In Canada, the growing geriatric population is also fueling the growth. As per the World Population Ageing Report, in Canada, there were around 6.602 million people aged over 65 years in 2019, and the number is estimated to reach 11.436 million by 2050. The demand for aesthetic fillers is expected to increase due to increased attention on facial aesthetics among this population.

The presence of key players in the United States that are launching new products in the market, gives an edge to the country in the global market. In January 2020, Revance Therapeutics reported that transformative aesthetics portfolio transaction with exclusive United States distribution agreement of Food and Drug Administration approved dermal fillers from Teoxane SA. TEOXANE SA RHA portfolio is one of the first FDA-approved dermal fillers for correction of dynamic wrinkles. These factors are driving the growth of the market in the forecast period.

Competitive Landscape

The facial injections market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include AbbVie Inc (Allergan Plc), Anika Therapeutics Inc., Ipsen SA, Medytox Inc., Merz Pharma, Galderma Pharma SA, Sanofi SA, Sinclair Pharma Plc, Suneva Medical Inc., Alphaeon Corporation (Teoxane Laboratories) among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the facial injections market globally. For instance, in February 2022, Merz Aesthetics has Launched Radiesse (+) as the First and Only Aesthetic Injectable to Improve Moderate to Severe Loss of Jawline Contour.

AbbVie Inc (Allergan Plc)

Overview:

Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. The company is the maker of Botox.

Product Portfolio:

JUVEDERM VOLUMA XC: JUVEDERM VOLUMA XC injectable gel is for deep injection in the cheek area to correct age-related volume loss and for augmentation of the chin region to improve the chin profile in adults over 21.

Why Purchase the Report?

Visualize the composition of the global facial injections market segmentation by injection material type, application type, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global facial injections market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global facial injections market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global facial injections market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Facial Injections Market - By Injection Material Type

Collagen

Hyaluronic Acid

Calcium Hydroxyl Apatite

Botulinum Toxin

Global Facial Injections Market - By Application Type

Facial Line Correction

Lip Augmentation

Face Lift

Other

Global Facial Injections Market - By Region

North America

Europe

Asia-Pacific

Middle East & Africa

South America